CANX and colorectal cancer: Zheng et al. found that miR-148-3p serves as an oncogene by targeting on calnexin pathway, which suppresses the surface expression of MHC-I on tumor cells and inhibits the CD8+ T cell-dominated anticancer immunity in colorectal cancer [20].